Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Receivables (2019 - 2026)

ADC Therapeutics has reported Change in Receivables over the past 8 years, most recently at $1.9 million for Q1 2026.

  • Quarterly results put Change in Receivables at $1.9 million for Q1 2026, down 83.15% from a year ago — trailing twelve months through Mar 2026 was -$728000.0 (down 108.4% YoY), and the annual figure for FY2025 was $8.8 million, up 284.22%.
  • Change in Receivables reached $1.9 million in Q1 2026 per ADCT's latest filing, down from $6.2 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $42.7 million in Q4 2022 and bottomed at -$48.9 million in Q1 2023.
  • Median Change in Receivables over the past 5 years was -$2419.0 (2022), compared with a mean of $53529.4.
  • The largest annual shift saw Change in Receivables surged 298564.35% in 2022 before it tumbled 1410977.09% in 2023.
  • Over 5 years, Change in Receivables stood at $42.7 million in 2022, then crashed by 90.65% to $4.0 million in 2023, then tumbled by 192.87% to -$3.7 million in 2024, then surged by 266.63% to $6.2 million in 2025, then plummeted by 68.84% to $1.9 million in 2026.
  • Business Quant data shows Change in Receivables for ADCT at $1.9 million in Q1 2026, $6.2 million in Q4 2025, and -$3.3 million in Q3 2025.